Macabinta, Gemma .

HRN: 15-55-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2025
CEFUROXIME 500MG (TAB)
04/06/2025
04/12/2025
ORAL
500mg
2 Times A Day
NSVD, Intransit Delivery, First Degree Perineal Laceration
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: